YU11599A - Intermedijari za pravljenje inhibitora hiv-proteaze i postupci za pravljenje inhibitora hiv-proteaze - Google Patents

Intermedijari za pravljenje inhibitora hiv-proteaze i postupci za pravljenje inhibitora hiv-proteaze

Info

Publication number
YU11599A
YU11599A YU11599A YU11599A YU11599A YU 11599 A YU11599 A YU 11599A YU 11599 A YU11599 A YU 11599A YU 11599 A YU11599 A YU 11599A YU 11599 A YU11599 A YU 11599A
Authority
YU
Yugoslavia
Prior art keywords
protease inhibitors
making hiv
intermediates
hiv
methods
Prior art date
Application number
YU11599A
Other languages
English (en)
Inventor
Kathleen R. Whitten
Michael E. Deason
Original Assignee
Agouron Pharmaceuticals Inc.
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals Inc., Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals Inc.
Publication of YU11599A publication Critical patent/YU11599A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

HIV-proteazni inhibitri inhibiraju ili blokiraju biološku aktivnost HIV-proteaznog enzima što izaziva završavanje replikacije HIV virusa. Ova jedinjenja mogu da se dobiju pomoću novih postupaka predmetnog pronalaska uz korišćenje novih jedinjenja pronalaska i novih intermedijera.
YU11599A 1996-09-05 1997-09-04 Intermedijari za pravljenje inhibitora hiv-proteaze i postupci za pravljenje inhibitora hiv-proteaze YU11599A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05

Publications (1)

Publication Number Publication Date
YU11599A true YU11599A (sh) 2000-03-21

Family

ID=24845703

Family Applications (1)

Application Number Title Priority Date Filing Date
YU11599A YU11599A (sh) 1996-09-05 1997-09-04 Intermedijari za pravljenje inhibitora hiv-proteaze i postupci za pravljenje inhibitora hiv-proteaze

Country Status (33)

Country Link
EP (2) EP1361216B1 (sh)
JP (3) JP4149000B2 (sh)
KR (1) KR100563289B1 (sh)
CN (2) CN1183117C (sh)
AP (2) AP1322A (sh)
AT (2) ATE254603T1 (sh)
AU (2) AU740369B2 (sh)
BG (2) BG64793B1 (sh)
BR (1) BR9713192A (sh)
CA (1) CA2264756A1 (sh)
CZ (2) CZ298175B6 (sh)
DE (2) DE69734689T2 (sh)
DK (2) DK1361216T3 (sh)
EA (1) EA002051B1 (sh)
EE (1) EE04465B1 (sh)
ES (2) ES2210573T3 (sh)
GE (1) GEP20022799B (sh)
HK (1) HK1062171A1 (sh)
HU (1) HUP0000028A3 (sh)
IL (1) IL128567A (sh)
IS (1) IS2030B (sh)
NO (1) NO313287B1 (sh)
NZ (1) NZ334909A (sh)
OA (1) OA10988A (sh)
PL (2) PL198408B1 (sh)
PT (1) PT927165E (sh)
SG (1) SG94780A1 (sh)
SI (2) SI0927165T1 (sh)
SK (2) SK284899B6 (sh)
TR (1) TR199900473T2 (sh)
UA (1) UA67727C2 (sh)
WO (1) WO1998009951A2 (sh)
YU (1) YU11599A (sh)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
AU4953796A (en) * 1995-03-15 1996-10-02 Sanyko Company, Limited Dipeptide compounds having ahpba structure
EP0983999B8 (en) * 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
WO1997011938A1 (fr) * 1995-09-26 1997-04-03 Japan Tobacco Inc. Procede de production de derives amides et de leurs intermediaires
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
CZ230398A3 (cs) * 1996-02-24 1999-01-13 Basf Aktiengesellschaft Derivát pyrazol-4-ylhetaroylu, způsob jeho přípravy a herbicidní prostředek, který ho obsahuje

Also Published As

Publication number Publication date
CZ71699A3 (cs) 1999-06-16
ATE254603T1 (de) 2003-12-15
TR199900473T2 (xx) 1999-06-21
SI0927165T1 (en) 2004-04-30
PL198408B1 (pl) 2008-06-30
CN1537846A (zh) 2004-10-20
PL331801A1 (en) 1999-08-02
UA67727C2 (uk) 2004-07-15
PL201758B1 (pl) 2009-05-29
BG65237B1 (bg) 2007-09-28
DK1361216T3 (da) 2006-01-23
NZ334909A (en) 2000-06-23
CZ298175B6 (cs) 2007-07-11
WO1998009951A2 (en) 1998-03-12
AP9901497A0 (en) 1999-06-30
EE04465B1 (et) 2005-04-15
SK28299A3 (en) 1999-11-08
ES2252586T3 (es) 2006-05-16
EA002051B1 (ru) 2001-12-24
PT927165E (pt) 2004-04-30
SK284899B6 (sk) 2006-02-02
HUP0000028A3 (en) 2003-05-28
EA199900257A1 (ru) 1999-08-26
SI1361216T1 (sl) 2006-02-28
JP2001500495A (ja) 2001-01-16
EP0927165A2 (en) 1999-07-07
KR20010029489A (ko) 2001-04-06
CN1232455A (zh) 1999-10-20
DE69726298T2 (de) 2004-05-27
IS2030B (is) 2005-08-15
DE69726298D1 (de) 2003-12-24
CN1183117C (zh) 2005-01-05
AU766155B2 (en) 2003-10-09
EP1361216A1 (en) 2003-11-12
AU740369B2 (en) 2001-11-01
OA10988A (en) 2001-11-01
AP2003002938A0 (en) 2003-12-31
EP0927165B1 (en) 2003-11-19
SK285278B6 (sk) 2006-10-05
DK0927165T3 (da) 2004-03-15
GEP20022799B (en) 2002-09-25
AP1322A (en) 2004-11-04
NO991072D0 (no) 1999-03-04
KR100563289B1 (ko) 2006-03-22
CA2264756A1 (en) 1998-03-12
IL128567A (en) 2004-03-28
AU1473602A (en) 2002-03-14
JP4149000B2 (ja) 2008-09-10
NO313287B1 (no) 2002-09-09
BG64793B1 (bg) 2006-04-28
NO991072L (no) 1999-03-04
BG103305A (en) 2000-01-31
CN1305854C (zh) 2007-03-21
EP1361216B1 (en) 2005-11-16
WO1998009951A3 (en) 1998-07-09
SG94780A1 (en) 2003-03-18
AU4331797A (en) 1998-03-26
IL128567A0 (en) 2000-01-31
ES2210573T3 (es) 2004-07-01
EE9900109A (et) 1999-12-15
HUP0000028A2 (hu) 2000-05-28
DE69734689D1 (de) 2005-12-22
IS4982A (is) 1999-02-19
CZ298174B6 (cs) 2007-07-11
ATE309990T1 (de) 2005-12-15
JP2008056693A (ja) 2008-03-13
JP2008088178A (ja) 2008-04-17
BR9713192A (pt) 1999-12-21
HK1062171A1 (en) 2004-10-21
DE69734689T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
DK1305286T3 (da) Cyclopentanoindoler, præparater indeholdende sådanne forbindelser og fremgangsmåder til behandling
DK0813525T3 (da) Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
BR9908280A (pt) Inibidores de enzimas de fosfolipase
EA199700361A1 (ru) Ингибиторы ферментативной активности ротамазы, являющиеся малыми молекулами
BR9712085A (pt) Inibidores de metaloprotease heterocìclicos
NO982774D0 (no) Inhibitorer for Interleukin-1<beta>-konverterende enzym
DK0966465T3 (da) Inhibitorer af IMPDH-enzymer
PT1017692E (pt) 4-heteroaril-tetrahidroquinolinas e sua aplicacao como inibidores da proteina de transferencia de ester de colesterol (ctep)
DE69432035D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
DK1261368T3 (da) Tværbunden, ikke-fungal lipaseholdig sammensætning og fremgangsmåder til anvendelse deraf
DE69937888D1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
NO990708L (no) Bisykliske pyrimidinderivater og deres anvendelse som antikoagulanter
ES2188979T3 (es) Derivados de benzamidina sustituidos con derivados de aminoacidos ciclicos e hidroxiacidos ciclicos, y su uso como anti-coagulantes.
ES2117123T3 (es) Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
HN2001000217A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa - 7
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
DE60042209D1 (de) Enzymatische synthese von deoxyribonucleotiden
MY132553A (en) Methods of making hiv-protease inhibitors and intermediates for making hiv-protease inhibitors
DE60101224D1 (de) Hydroxamsäure derivate
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
YU11599A (sh) Intermedijari za pravljenje inhibitora hiv-proteaze i postupci za pravljenje inhibitora hiv-proteaze